Glaxosmithkline Consumer Healthcare Limited, a amalgamated public limited company, was established on 30 October 1958 in Nabha, Punjab, India. Engaging in organic & health foods within the food and beverages sector, it holds CIN: L24231PB1958PLC002257. Registered under ROC Roc Chandigarh. it is listed. It has an authorized capital of ₹60.00 Cr and a paid-up capital of ₹42.06 Cr.
It upholds a compliant status. In 2019, it reported revenue of ₹5,214.61 Cr and a net worth of ₹4,094.71 Cr. Employing 1,297 professional, Its leadership includes Pradeep Vasudeo Bhide (Director), Nitin Mathur (Cfo), Sangeeta Talwar (Director). Past directors included Vivek Anand, Pradeep Vasudeo Bhide, Naresh Dayal. It holds no open charges and ₹279.50 Cr settled loans. Its latest AGM occurred on 02 August 2019, with the balance sheet filed on 31 March 2019. It is based at Patiala Road,Nabha, Distt. Patiala, Nabha, Punjab, 147201.
L24231PB1958PLC002257
002257
30 October 1958
₹60.00 Cr
₹42.06 Cr
Roc Chandigarh
Listed
Amalgamated
Explore comprehensive insights into Glaxosmithkline Consumer Healthcare Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pradeep Vasudeo Bhide | Director | 10 May 2019 | Current |
| Nitin Mathur | Cfo | 01 Nov 2019 | Current |
| Sangeeta Talwar | Director | 06 Aug 2014 | Current |
| Patnam Dwarakanath | Nominee Director | 09 Apr 2013 | Current |
| Navneet Saluja | Managing Director | 01 Jan 2018 | Current |
| Subramanian Madhavan | Director | 25 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 27 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 02 Aug 2019 | Past |
| Pramod Abcsdd | Director | 02 Aug 2019 | Past |
| Pramod Abcsdd | Director | 27 Apr 2007 | Past |
| Pramod Abcsdd | Whole-Time Director | 31 Aug 2016 | Past |
| Pramod Abcsdd | Director | 31 Mar 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glaxosmithkline Consumer Healthcare Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 12.52% increase. The company also saw a substantial improvement in profitability, with a 40.38% increase in profit. The company's net worth Soared by an impressive increase of 17.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Glaxosmithkline Consumer Healthcare had a promoter holding of 72.46% and a public holding of 27.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,795,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2006 | Deutsche Bank | ₹53.00 Cr | Satisfied |
| 26 Jul 1995 | Bank Of America | ₹200.00 Cr | Satisfied |
| 23 Mar 1993 | Bank Of America Nt And Sa | ₹26.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Glaxosmithkline Consumer Healthcare has a workforce of 1297 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Glaxosmithkline Consumer Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glaxosmithkline Consumer Healthcare's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nitin Mathur was appointed as a CFO was appointed as a CFO on 01 Nov 2019 & has been associated with this company since 6 years 1 month . was recorded as a recent event.
Progress on Nitin Mathur was appointed as a CFO was appointed as a CFO on 01 Nov 2019 & has been associated with this company since 6 years 1 month . was documented.
Progress on Glaxosmithkline Consumer Healthcare Limited last Annual general meeting of members was held on 02 Aug 2019 as per latest MCA records. was documented.
Pradeep Vasudeo Bhide was appointed as a Director was appointed as a Director on 10 May 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
Progress on Glaxosmithkline Consumer Healthcare Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chandigarh. was documented.
Progress on Subramanian Madhavan was appointed as a Director was appointed as a Director on 25 Sep 2018 & has been associated with this company since 7 years 3 months . was documented.
"CCI approves GSKCH-HUL merger worth Rs 31,700 crore. Still need other approvals. Unilever bought Horlicks and Boost for Rs 27,750 crore. GSKCH is top in HFD with Horlicks and Boost.".
On December 03, Hindustan Unilever Limited (HUL)—an India-based fast moving consumer goods company— announced its board’s approval on its merger with GlaxoSmithKline Consumer Healthcare (GSKCH... .
The CIN of Glaxosmithkline Consumer Healthcare Limited is L24231PB1958PLC002257.
Glaxosmithkline Consumer Healthcare Limited is headquartered at Patiala Road,Nabha, Distt. Patiala, Nabha, Punjab, 147201.
Glaxosmithkline Consumer Healthcare Limited was incorporated on 30 October 1958.
The current directors of Glaxosmithkline Consumer Healthcare Limited are
The primary industry of Glaxosmithkline Consumer Healthcare Limited is Food And Beverages.
Glaxosmithkline Consumer Healthcare Limited is listed.
The authorized capital of Glaxosmithkline Consumer Healthcare Limited is ₹60.00 Cr, and the paid-up capital is ₹42.06 Cr.
The compliance status of Glaxosmithkline Consumer Healthcare Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX